143 related articles for article (PubMed ID: 28356807)
1. Increasing attendance in a cervical cancer screening programme by personal invitation: experience of a Lithuanian primary health care centre.
Kurtinaitienė R; Rimienė J; Labanauskaitė I; Lipunova N; Smailytė G
Acta Med Litu; 2016; 23(3):180-184. PubMed ID: 28356807
[TBL] [Abstract][Full Text] [Related]
2. Organised Versus Opportunistic Cervical Cancer Screening in Urban and Rural Regions of Lithuania.
Paulauskiene J; Ivanauskiene R; Skrodeniene E; Petkeviciene J
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31500116
[No Abstract] [Full Text] [Related]
3. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
4. Encouraging attendance at a screening mammography programme: determinants of response to different recruitment strategies.
Schofield PE; Cockburn J; Hill DJ; Reading D
J Med Screen; 1994 Jul; 1(3):144-9. PubMed ID: 8790507
[TBL] [Abstract][Full Text] [Related]
5. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
6. The Cost-Effectiveness Analysis of Cervical Cancer Screening Using a Systematic Invitation System in Lithuania.
Paulauskiene J; Stelemekas M; Ivanauskiene R; Petkeviciene J
Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31835649
[TBL] [Abstract][Full Text] [Related]
7. [Women's social conditions and their participation in Cervical Cancer Population Screening Program in Poland].
Spaczyński M; Nowak-Markwitz E; Januszek-Michalecka L; Karowicz-Bilińska A
Ginekol Pol; 2009 Nov; 80(11):833-8. PubMed ID: 20088397
[TBL] [Abstract][Full Text] [Related]
8. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
9. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
Abdul Rashid RM; Dahlui M
Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
[TBL] [Abstract][Full Text] [Related]
10. Effect of Fee on Cervical Cancer Screening Attendance--ScreenFee, a Swedish Population-Based Randomised Trial.
Alfonzo E; Andersson Ellström A; Nemes S; Strander B
PLoS One; 2016; 11(3):e0150888. PubMed ID: 26986848
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the effectiveness of cervical cancer screening invitation letters.
Decker KM; Turner D; Demers AA; Martens PJ; Lambert P; Chateau D
J Womens Health (Larchmt); 2013 Aug; 22(8):687-93. PubMed ID: 23915107
[TBL] [Abstract][Full Text] [Related]
12. Sociodemographic and lifestyle determinants of non-attendance for cervical cancer screening in Lithuania, 2006-2014.
Petkeviciene J; Ivanauskiene R; Klumbiene J
Public Health; 2018 Mar; 156():79-86. PubMed ID: 29408192
[TBL] [Abstract][Full Text] [Related]
13. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
[TBL] [Abstract][Full Text] [Related]
14. Impact of invitation and reminder letters on cervical cancer screening participation rates in an organized screening program.
Tavasoli SM; Pefoyo AJ; Hader J; Lee A; Kupets R
Prev Med; 2016 Jul; 88():230-6. PubMed ID: 27143497
[TBL] [Abstract][Full Text] [Related]
15. A primary healthcare-based intervention to improve a Danish cervical cancer screening programme: a cluster randomised controlled trial.
Jensen H; Svanholm H; Støvring H; Bro F
J Epidemiol Community Health; 2009 Jul; 63(7):510-5. PubMed ID: 19228681
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of predictors of attendance for breast screening in inner London.
Sutton S; Bickler G; Sancho-Aldridge J; Saidi G
J Epidemiol Community Health; 1994 Feb; 48(1):65-73. PubMed ID: 8138773
[TBL] [Abstract][Full Text] [Related]
17. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.
Broberg G; Gyrd-Hansen D; Miao Jonasson J; Ryd ML; Holtenman M; Milsom I; Strander B
Int J Cancer; 2014 May; 134(9):2223-30. PubMed ID: 24127304
[TBL] [Abstract][Full Text] [Related]
18. Probability of early repeat Pap smear in an integrated cervical screening programme.
Rosso A; Foglietta F; Naldoni C; Schincaglia P; Buzzi G; Camprincoli S; Serafini M; Busoli S; Leoni F; Grilli N; Bucchi L
Eur J Cancer Prev; 2000 Aug; 9(4):269-74. PubMed ID: 10958330
[TBL] [Abstract][Full Text] [Related]
19. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer.
Eaker S; Adami HO; Granath F; Wilander E; Sparén P
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):346-54. PubMed ID: 15006907
[TBL] [Abstract][Full Text] [Related]
20. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.
Sancho-Garnier H; Tamalet C; Halfon P; Leandri FX; Le Retraite L; Djoufelkit K; Heid P; Davies P; Piana L
Int J Cancer; 2013 Dec; 133(11):2681-7. PubMed ID: 23712523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
